Inceptor Bio

Inceptor Bio is a biotechnology company focused on developing innovative cell therapy solutions aimed at treating difficult-to-treat cancers. The company emphasizes novel mechanisms to enhance the performance of immune cells within the tumor microenvironment. By collaborating with university research programs, Inceptor Bio leverages its laboratory and manufacturing capabilities, along with the expertise of its cell and gene therapy specialists, to efficiently translate cutting-edge therapeutic approaches into clinical applications. Its platform is dedicated to identifying, incubating, and accelerating new technologies in cell and genetic therapy, ultimately striving to improve cancer treatment outcomes for patients.

Derek Hennecke

Partner

Shailesh Maingi

Founder and CEO

Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.